Fc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced Cancer

Clinical trial NCT03860272 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03860272
Sponsor: Agenus Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Cancer Angiosarcoma Colorectal Cancer Without Liver Metastases Endometrial Cancer Fibrolamellar Carcinoma Non-small-cell Lung Cancer Ovarian Cancer Prostate Cancer

Start date: 2019-03-20
Primary completion: 2025-01-13
Enrollment: 499

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.